Gender differences in germ-cell mutagenesis and genetic risk

Area of Science:

• Toxicology
• Genetics
• Reproductive Biology

Background:

• International chemical mutagen classification systems are hazard-based, not quantitatively risk-assessing.
• Germ-cell mutagenicity testing has historically used limited mutagens and rarely compared gender-specific susceptibilities.
• Significant biological differences exist between males and females in gametogenesis, potentially impacting mutagen susceptibility and risk.

Purpose of the Study:

• To review the literature on gender-specific differences in germ-cell mutagenicity.
• To highlight the need for quantitative risk assessment in mutagenicity testing.
• To emphasize the importance of investigating gender-specific genetic effects and epigenetic alterations.

Main Methods:

• Critical review of existing scientific literature.
• Analysis of gender-specific differences in germ cell development and response to mutagens.
• Evaluation of current mutagenicity testing methodologies.

Main Results:

• Gender differences significantly influence susceptibility, sensitivity stages, and risks for gene mutations and chromosomal aberrations in germ cells.
• Offspring health and future generations may be threatened by gender-specific transmission of germ-cell mutations and imprinting pattern alterations.
• Standard mutagenicity tests may not fully capture genetic effects from varying exposure types (acute vs. chronic low-dose).

Conclusions:

• Urgent research is required to identify genetic hazards of a wider range of chemicals, including those affecting chromosome segregation.
• Epigenetic programming alterations and their health consequences, particularly gender-specific effects, need thorough investigation.
• Expanding the germ-cell mutagen database with molecular methods and conducting genetic epidemiology studies are crucial for verifying human genetic risk.